emtricitabine/tenofovir disoproxil accordpharma
accord healthcare b.v. - emtricitabinas/tenofoviro dizoproksilis - plėvele dengtos tabletės - 200 mg/245 mg (300 mg); 200 mg/245 mg - tenofovir disoproxil and emtricitabine
ambrisentan norameda
norameda, uab - ambrisentanas - plėvele dengtos tabletės - 5 mg - ambrisentan
ambrisentan zentiva
zentiva k.s. - ambrisentanas - plėvele dengtos tabletės - 10 mg - ambrisentan
livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - citomegalovirusinės infekcijos - antivirusiniai vaistai sisteminiam naudojimui - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). reikėtų atsižvelgti į oficialius nurodymus, kaip tinkamai naudoti antivirusinių medžiagų.
reconcile
forte healthcare limited - fluoksetinas - psichoanaleptikai - Šunys - kaip pagalbinė priemonė gydant atskyrimu susijusių sutrikimų šunims pasireiškia sunaikinimo ir netinkamo elgesio (vocalisation ir netinkami tuštinimosi ir / ar šlapinimasis) ir tik kartu su elgsenos modifikavimo metodai.
revolade
novartis europharm limited - eltrombopag - purpura, trombocitopenija, idiopatinė - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ir 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ir 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
biotum
pharmaceutical works polpharma s.a. - ceftazidimas pentahidratas - milteliai injekciniam ar infuziniam tirpalui - 1 g - ceftazidime
ceftazidime kabi
fresenius kabi polska sp.z.o.o. - ceftazidimas pentahidratas - milteliai injekciniam ar infuziniam tirpalui - 1000 mg; 500 mg; 2000 mg - ceftazidime
ceftazidime mip
mip pharma gmbh - ceftazidimas - milteliai injekciniam ar infuziniam tirpalui - 1 g; 2 g - ceftazidime
fortum
glaxosmithkline lietuva, uab - ceftazidimas pentahidratas - milteliai injekciniam ar infuziniam tirpalui - 2 g; 1 g; 3 g; 500 mg - ceftazidime